| Trial ID: | L5407 |
| Source ID: | NCT00147836
|
| Associated Drug: |
Human Insulin (Novolin-R, Novo Nordisk)
|
| Title: |
Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Human Insulin (Novolin-R, Novo Nordisk)|DEVICE: H-Tron Plus V100; Disetronic Medical System, Burgdorf, Switzerland|OTHER: Pre-meal|DRUG: Novolin-R|DRUG: Human Insulin NPH (Novolin-N, Novo Nordisk)|DRUG: Gliclazide (Diamicron, Servier)|DRUG: Diamicron and Glucophage
|
| Outcome Measures: |
Primary: glycemic control, the improvement of β-cell l function and the remission rate after short intensive therapy in newly diagnosed type 2 diabetic patients, Oct. 2007 | Secondary: the effects of different interventions (oral anti-hyperglycemic agents, multiple daily injections and continuous subcutaneous insulin infusion) on glycemic control, β-cell function and the remission rate in newly-diagnosed type 2 diabetic patients, Oct. 2007
|
| Sponsor/Collaborators: |
Sponsor: Sun Yat-sen University | Collaborators: Ministry of Education, China|Guangdong Science and Technology Bureau, China|Hoffmann-La Roche|Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
436
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-09
|
| Completion Date: |
2007-10
|
| Results First Posted: |
|
| Last Update Posted: |
2008-04-01
|
| Locations: |
the first Affiliated Hospital of Sun Yat-Sen university, Guangzhou, Guangdong, 510080, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00147836
|
